Found 21 matching trials
Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg
PHASE1The objective of this study was to investigate the bioequivalence of Mylan'...
Location
PRACS Institute, Ltd.
Trial of Topical Verapamil in Chronic Rhinosinusitis With Nasal Polyps
PHASE1Verapamil is an L-type calcium channel blocker(CCB) which has been shown to...
Location
Massachusetts Eye and Ear
Verapamil Effect in Cystic Fibrosis-related Dysglycemia
PHASE2The investigators are conducting a pilot open-label pre/post interventional...
Location
Diabetes Research Center, Massachusetts General Hospital
Comparison of Intralesional Triamcinolone Acetonide Treatment With Intralesional Verapamil Hydrochloride in Keloids
NAThe paucity of local literature regarding the comparison of intralesional v...
Location
Bahawal Victoria Hospital/Quaid-e-Azam Medical College
Comparing Two Heart Medicines for Fast, Irregular Heartbeat (Atrial Fibrillation)
PHASE4The goal of this clinical trial is to learn whether intravenous verapamil o...
Location
Multiple Locations
Comparative Bioavailability Study of Synerx and Verelan PM 300 mg Verapamil HCl ER Capsules Under Fed Conditions
PHASE1The purpose of this study is to determine the bioequivalency of Synerx Phar...
Location
Multiple Locations
Study of the Electrocardiographic Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects
PHASE1This study seeks to compare 4 known QT prolonging drugs versus placebo to d...
Location
Multiple Locations
Fasting Study of Verapamil HCl Extended-Release Capsules 300 mg to Verelan® PM Extended-Release Capsules 300 mg
PHASE1The objective for this study was to investigate the bioequivalence of Mylan...
Location
PRACS Institute, Ltd.
Drug-Drug Interaction Between Colchicine and Verapamil ER
PHASE1Colchicine is a substrate for both cytochrome P450 3A4 (CYP3A4) and P-glyco...
Location
PRACS Institute, Ltd. - Cetero Research
Food Study of Verapamil HCl Extended-Release Capsules 300 mg and Verelan® PM Extended-Release Capsules 300 mg
PHASE1The objective for this study was to investigate the bioequivalence of Mylan...
Location
PRACS Institute, Ltd.